← Back to patent-cliff list
Telmisartan/Verapamil Hydrochloride
Tier C — Watch / tradeTelmisartan/Verapamil Hydrochloride
Honeybrains Biotech LLC
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：AT1, VDCCs
Indications (approved)：Panic disorder
Regional status
US
Phase II
2022-02-03
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Telmisartan/Verapamil Hydrochloride?
Approved indications include: Panic disorder.
When does the Telmisartan/Verapamil Hydrochloride patent expire?
No public expiry year is available for Telmisartan/Verapamil Hydrochloride yet; this page updates once verified.
How do I get a quote for Telmisartan/Verapamil Hydrochloride intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-05